During the presidential debate, former President Donald Trump and Vice President Kamala Harris shared their differing visions ...

Adding bevacizumab to the combination therapy of carboplatin and paclitaxel significantly improved progression-free survival ...

Policy changes, such as banning spread pricing and promoting transparency, are necessary to realign the pharmacy benefit ...

New research reveals disparities in opioid prescribing by race among Medicare beneficiaries, sparking concerns about ...

The European approval comes months after the FDA’s approval of the first-of-its-kind treatment for pulmonary arterial ...

Matthew Smeltzer, PhD, University of Memphis, shares insights into his team's quality-of-care initiative to identify and ...

A new report based on patient focus groups suggests many clinicians can do more to help patients with sickle cell disease ...

An AI segmentation system was able to identify changes in retinal segmented features based on optical coherence tomography ...

Social frailty in patients with acute exacerbations of chronic obstructive pulmonary disease (COPD) does not directly impact ...

Speakers at the 2024 World Conference on Lung Cancer discussed the considerations that must go into designing and performing ...

During ESMO Congress 2024, sessions will focus on hot topics in therapeutic areas, such as antibody-drug conjugates; the latest trial data; health policy; and advances in technology.

Dr. Jesudian and Dr. Amin discuss improving outcomes in hepatic encephalopathy (HE) through provider-payer collaboration, stressing accurate diagnosis, medication access, and follow-up care. They ...